Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:01:57.046Z.
Calculation as of: 2026-10-06T20:01:57.046Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5d6bd3278d76725a85d4cb05495e45b99d0fd89b23371e3701c8289362793e8f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Design Therapeutics, Inc.
Market Cap
$747.61M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.02M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.37M
Free Cash Flow Yield
6.94%
TTM Avg
7.62%
3Y Avg
7.21%
5Y Avg
5.53%
Market Cap
$765.30M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$723.18M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$721.69M
Free Cash Flow Yield
N/A
TTM Avg
23.05%
3Y Avg
23.09%
5Y Avg
23.09%
Market Cap
$776.24M
Free Cash Flow Yield
N/A
TTM Avg
1.71%
3Y Avg
1.71%
5Y Avg
1.71%
Market Cap
$777.34M
Free Cash Flow Yield
N/A
TTM Avg
46.69%
3Y Avg
46.69%
5Y Avg
28.31%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $747.61M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 6.94% | 7.62% | 7.21% | 5.53% |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | 23.05% | 23.09% | 23.09% |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 1.71% | 1.71% | 1.71% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | N/A | 46.69% | 46.69% | 28.31% |
| Varex Imaging Corporation (VREX)vs › | $778.01M | N/A | 6.80% | 7.30% | 6.57% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
